We are live on ! Find out more
VERA icon

Vera Therapeutics
VERA

31 hedge funds and large institutions have $252M invested in Vera Therapeutics in 2021 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 3

129% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 7

41% more funds holding

Funds holding: 22 → 31 (+9)

36% more capital invested

Capital invested by funds: $186M → $252M (+$66.3M)

0.94% more ownership

Funds ownership: 69.21% → 70.15% (+0.94%)

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

Holders
31
Holders Change
+9
Holders Change %
+40.91%
% of All Funds
0.54%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
16
Increased
7
Reduced
3
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$5.6M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$3.46M
3
JP Morgan Chase
JP Morgan Chase
New York
+$1.41M
4
State Street
State Street
Massachusetts
+$1.35M
5
Northern Trust
Northern Trust
Illinois
+$1.06M

Top Sellers

Rank Fund Capital Flow
1
OCA
Octagon Capital Advisors
New York
-$7.8M
2
Millennium Management
Millennium Management
New York
-$1.08M
3
PHP
Parkman Healthcare Partners
Connecticut
-$894K
4
MIM
Monashee Investment Management
Massachusetts
-$611K
5
CCM
CAAS Capital Management
New York
-$265K
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$52.6M +$302K +16,890 +0.5%
A
2
Abingworth
United Kingdom
$51.4M – – –
SI
3
Sofinnova Investments
California
$50.6M – – –
Citadel Advisors
4
Citadel Advisors
Florida
$29.1M -$185K -10,345 -0.6%
KXA
5
KPCB XVI Associates
California
$23.3M – – –
AI
6
Alphabet Inc
California
$16.4M – – –
OCA
7
Octagon Capital Advisors
New York
$12.1M -$7.8M -436,545 -39%
BlackRock
8
BlackRock
New York
$5.45M +$5.6M +313,444 +52,857%
Vanguard Group
9
Vanguard Group
Pennsylvania
$4.26M +$3.46M +193,567 +370%
JP Morgan Chase
10
JP Morgan Chase
New York
$1.36M +$1.41M +78,652 New
State Street
11
State Street
Massachusetts
$1.31M +$1.35M +75,255 New
Geode Capital Management
12
Geode Capital Management
Massachusetts
$1.24M +$993K +55,532 +345%
Northern Trust
13
Northern Trust
Illinois
$1.03M +$1.06M +59,315 New
PHP
14
Parkman Healthcare Partners
Connecticut
$445K -$894K -50,000 -66%
Morgan Stanley
15
Morgan Stanley
New York
$382K +$362K +20,222 +1,134%
GTCM
16
Gyon Technologies Capital Management
New Jersey
$330K +$340K +19,042 New
RJFSA
17
Raymond James Financial Services Advisors
Florida
$309K – – –
Charles Schwab
18
Charles Schwab
California
$295K +$303K +16,948 New
Bank of New York Mellon
19
Bank of New York Mellon
New York
$230K +$236K +13,224 New
Bank of America
20
Bank of America
North Carolina
$113K +$5.52K +309 +5%
Deutsche Bank
21
Deutsche Bank
Germany
$71K +$72.7K +4,068 New
AIG
22
American International Group
New York
$67K +$69.1K +3,867 New
California State Teachers Retirement System (CalSTRS)
23
California State Teachers Retirement System (CalSTRS)
California
$66K +$68.2K +3,817 New
SO
24
STRS Ohio
Ohio
$27K +$28.6K +1,600 New
New York State Common Retirement Fund
25
New York State Common Retirement Fund
New York
$21K +$21.5K +1,200 New
1
2

VERA Hedge Fund Activity: Q3 2021 in Review

31 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Vera Therapeutics (VERA) for Q3 2021, worth a combined $252M — up 36% from $186M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new VERA positions and 7 closed out — a net gain of 9 holders — while 7 added to existing stakes and 3 trimmed.

The largest buyer was BlackRock, adding an estimated $5.6M. The largest seller was Octagon Capital Advisors, cutting an estimated $7.8M.

  • 31 institutional investors held Vera Therapeutics (VERA) as of Q3 2021, up from 22 in Q2 2021.
  • Funds reported $252M of Vera Therapeutics stock for Q3 2021, up 36% quarter-over-quarter.
  • 16 funds opened new Vera Therapeutics positions in Q3 2021 and 7 closed out, a net change of +9 holders.
  • The largest Vera Therapeutics buyer in Q3 2021 was BlackRock, an estimated $5.6M added.
  • The largest Vera Therapeutics seller in Q3 2021 was Octagon Capital Advisors, an estimated $7.8M sold.

Based on aggregated 13F filings for Q3 2021.